Ocuphire Chalks Up Another Phase III Success For Nyxol

 
• By Alaric DeArment
  
Ocuphire announced positive data from a pivital study of Nyxol in night vision disturbance • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business